April 25, 2007 - BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has submitted to the FDA the first assay for the rapid and simultaneous identification of methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) from patients with positive blood cultures.
This assay will enable physicians to implement the right treatment at the right time for patients with bloodstream infections, transforming patient care and significantly reducing healthcare costs.